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Severe intraprosthetic regurgitation following trans-catheter aortic valve
implantation-to crimp or not to crimp? This might be the problem
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generation of trans-catheter aortic valve prostheses
implanted through a trans-apical or a transfemoral access
[1]. Unfortunately, advanced technologies and innovative
surgical techniques can be at the origin of unknown
complications that affect negatively patient outcome.
In this evolving scenario, we all know that one of the main
complications that occurs immediately after the deployment
of the stent valve is a severe paravalvular leak due to the
valve malpositioning, incomplete valve deployment, pre-
sence of heavily asymmetric calcifications in the aortic
annulus or due to an error in the stent-valve sizing [2].
However, it is quite obvious that this is not the only form of
stent-valve leak a surgeon or an interventional cardiologist
can face during standard transcatheter aortic valve implan-
tation (TAVI) procedures.
In fact, as well underlined by Al-Attar and colleagues in
their case report [3], notonly theparavalvular leakbutalso the
intraprosthetic regurgitation is a potentially life-threatening
complication that may affect any trans-catheter aortic valve
procedure, regardless of the way of introduction. In their
reported case, the major intravalvular regurgitation due to
one leaflet immobility, rapidly and severely affected the left
ventricular function and all attempts to recover the hemo-
dynamic status failed (in particular, the positioning of a second
stent valvewithin the first one and the use of a femorofemoral
extracorporeal membrane oxygenation (ECMO)).
In our center and duringmy personal activity as proctor for
trans-apical TAVI procedures (62 trans-apical TAVI in 2 years),
I have also experienced the onset of this complication two
times: in one case (in our institute), the immobility of the
stent-valve leaflet was transient and the cuspmotion restored
few minutes after the valve deployment, when our anesthe-
siology team increased the patient’s systolic blood pressure
above 130 mm Hg: the transesophageal echocardiographic
evaluation confirmed the restoration of the valve hemody-
namic and thepostoperative recoverywas uneventful. Towhat
may concern the second trans-apical patient (a proctoring
case), the cusp immobility was irreversible and all attempts to
solve the problem failed: in this critical scenario, we urgently
implanted a second stent valve within the first one and the
hemodynamic status ameliorated consequently, with no need
for cardiopulmonary assistance.
Hence, I surmise that this complication occurs more often
than expected and further investigations are mandatory. In
particular, one of the most critical phases in TAVI procedures
remains the crimping process (for balloon-expandable stent
valves) and it is plausible that leafletsmightbedamagedduring
this process (crimping with high strength is never recom-mended): as suggested by Al-Attar and colleagues, the hooking
of the leaflet on the stent during the crimping phase can be at
the origin of its transient or irreversible immobility [3].
Another hypothesis is that broken calcifications in the
aortic annulus might determine cusp immobility during the
valve deployment, following a nonclear mechanism (anchor-
ing of the leaflet through the stent? Microfractures within the
stent hooking the cusp?).
Moreover, the asymmetrical stent-valve deployment may
be a (rare) cause of limited cusp motion; however, in this
situation, the echocardiographic evaluation will guide for a
valve re-ballooning.
However, the mechanism behind the intraprosthetic
regurgitation remains mostly unknown and we can only
suggest expedients to manage the complication. The
following conjectures may be considered.
During a standard TAVI and after the stent-valve deploy-
ment, presence of severe central regurgitation caused by a
frozen cusp:
1. The hemodynamic status is stable or can be stabilized
with acceptable doses of inotropic drugs.
- Control the position of the stiff guidewire (it can be at
the origin of temporary leaflet immobilization). Try to
place the guidewire in the valve orifice to evaluate the
leaflet motion.
- Verify the stent-valve shape and re-balloon in case of
distortion.
- Increase the systolic pressure (above 120 mm Hg) to
mobilize the frozen leaflet from the stent. (When the
leaflet moves and the valve is competent, a second
stent valve is not necessary. However, if the leaflet
seems damaged we recommend a second valve.)
- Consider employing the pigtail placed into the ascend-
ing aorta to carefully mobilize the fixed cusp (it might
be dangerous for the valve integrity).
2. The hemodynamic status is critical and it cannot be
ameliorated with high doses of inotropic drugs (dangerous
scenario).
- Urgent implantation of a second stent valve within the
first one seems to be the salvage procedure, regardless
of the cause; and
- Consider an ECMO or a femorofemoral cardiopulmonary
bypass to stabilize the hemodynamic.
Following these reflections, I strongly advocate the
presence of a cardiac surgery team with available cardiopul-
monary bypass equipment during all TAVI procedures. More-
over, I surmise that, when this complication occurs during
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transesophageal echocardiographic control, angiographic im-
aging alone is inadequate to evaluate the severity of the
intraprosthetic regurgitation and themechanism behind it [4].
In conclusion, further clinical reports are welcome and, in
particular, the crimping system for balloon-expandable stent
valves should be compared with the self-expandable stent-
valve system, with particular regard to cusp damages and to
stent integrity.
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